Merck & Co Inc (NYSE:MRK)
| 78.33 BATS BZX Real-Time Price As of Oct 15 |  0.00 / 0.00%Today’s Change | 68.38 Today|||52-Week Range 84.56 | +0.42% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 78.33 |
| Today’s open | 78.28 |
| Day’s range | 77.99 - 79.05 |
| Volume | 12,866,845 |
| Average volume (3 months) | 12,870,048 |
| Market cap | $198.3B |
Data as of 5:57pm ET, 10/15/2021
Growth & Valuation
| Earnings growth (last year) | -27.21% |
| Earnings growth (this year) | -0.78% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +3.06% |
| P/E ratio | 32.0 |
| Price/Sales | 4.33 |
| Price/Book | 7.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | +0.03 | +0.03% |
| AZNAstraZeneca | 0.00 | 0.00% |
| NVSNovartis | +0.01 | +0.01% |
| NVONovo Nordisk | +0.04 | +0.04% |
Data as of 5:36pm ET, 10/15/2021
Financials
| Next reporting date | October 28, 2021 |
| EPS forecast (this quarter) | $1.54 |
| Annual revenue (last year) | $48.0B |
| Annual profit (last year) | $7.1B |
| Net profit margin | 14.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
Chart unavailable
